NO760052L - - Google Patents
Info
- Publication number
- NO760052L NO760052L NO76760052A NO760052A NO760052L NO 760052 L NO760052 L NO 760052L NO 76760052 A NO76760052 A NO 76760052A NO 760052 A NO760052 A NO 760052A NO 760052 L NO760052 L NO 760052L
- Authority
- NO
- Norway
- Prior art keywords
- weight
- wet
- solution
- nappy
- amount
- Prior art date
Links
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 5
- 206010040880 Skin irritation Diseases 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 210000004392 genitalia Anatomy 0.000 claims description 4
- 230000036556 skin irritation Effects 0.000 claims description 4
- 231100000475 skin irritation Toxicity 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000002657 fibrous material Substances 0.000 claims description 3
- 238000009736 wetting Methods 0.000 claims description 3
- 230000003113 alkalizing effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 22
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Description
Foreliggende oppfinnelse vedrorer en losning for behandlingThe present invention relates to a solution for treatment
av hudirritasjoner samt en med denne fremstillet våtbleieof skin irritations as well as a wet nappy made with this
for spebarnspleie, d.v.s. en bleie som fuktes med den omtalte losningen, som inneholder substanser som motvirker den ut-vasking og alkalisering som gjentatte vaskinger og kontakt med urin og avforing har på spebarnshuden innenfor bleie-regionen. for infant care, i.e. a nappy that is moistened with the aforementioned solution, which contains substances that counteract the leaching and alkalization that repeated washings and contact with urine and faeces have on the infant's skin within the nappy region.
I de seneste årtier har man innen spebarnsverdenen gått overIn recent decades, there has been a shift in the infant world
til så godt som utelukkende å anvende bleier av absorberende, mykt cellulosemateriale som vanligvis anbringes ved hjelp av dertil egnede utformede plasttorklær. Slike bleier har en betraktelig evne til å suge opp så vel urin som avforing. to almost exclusively use nappies made of absorbent, soft cellulose material which are usually applied using specially designed plastic wipes. Such nappies have a considerable ability to absorb both urine and faeces.
Dette har fort til en tendens til å forskyve bleiebyttene, hvorved spebarnets hud i forholdsvis lang tid står i kontakt med såvel urin som avforing, hvilket igjen kan fore til hudirritasjoner samt oppvekst av en ikke onskelig bakterieflora. Vanligvis forsoker man å unngå slike virkninger ved å i sammenheng med bleiebyttene påfore huden legende og/eller bakteriedrepende salver, losninger eller pudder. Det har imidlertid vist seg at regelmessig anvendelse av bakteriedrepende preparat i denne sammenheng kan være skadelig for spebarnet. Til tross for dette er det vanskelig å unngå anvendelse av bakteriedrepende midler ved spebarnsstell, spesielt i anledning vanskeligheten med å oppnå kontroll over bakterier og sopp som candida albicans. This quickly tends to shift the nappy changes, whereby the infant's skin is in contact with both urine and faeces for a relatively long time, which in turn can lead to skin irritations and the growth of an undesirable bacterial flora. Usually one tries to avoid such effects by applying healing and/or bactericidal ointments, solutions or powders to the skin in connection with nappy changes. However, it has been shown that regular use of bactericidal preparations in this context can be harmful to the infant. Despite this, it is difficult to avoid the use of bactericidal agents in infant care, especially due to the difficulty in achieving control over bacteria and fungi such as candida albicans.
Ifolge foreliggende oppfinnelse har det imidlertid vist segAccording to the present invention, however, it has been shown
at man kan erstatte de vanligvis forekommende bakteriedrepende eller bakteriehemmende preparatene med en losning som inne- that you can replace the usually occurring bactericidal or bactericidal preparations with a solution that contains
holder natriumklorid og melkesyre ved en pH innen intervallet 3-6. Natriumkloridkonsentrasjonen i losningen er så lav at ingen svette forårsakes. Det har vist seg at en omtrentlig terskelverdi for forekomst av svette på erodert hud er en natriumkloridkonsentrasjon på 2 - 2,5%. Det er derfor ufor-delaktig å anvende hoyere konsentrasjoner enn den som forårsaker svette. Den laveste effektive natriumkloridkonsentrasjonen i losningen er omtrent o,5%. Det foretrekkes å anvende en natriumkloridkonsentrasjon på omtrent 1,5-2 vektsprosent. keeps sodium chloride and lactic acid at a pH within the range of 3-6. The sodium chloride concentration in the solution is so low that no sweating is caused. It has been shown that an approximate threshold value for the occurrence of sweat on eroded skin is a sodium chloride concentration of 2 - 2.5%. It is therefore disadvantageous to use higher concentrations than that which causes sweating. The lowest effective sodium chloride concentration in the solution is about 0.5%. It is preferred to use a sodium chloride concentration of about 1.5-2% by weight.
Innholdet av melkesyre i opplosningen er vanligvis omtrentThe lactic acid content of the solution is usually approx
o,5%, men også andre konsentrasjoner er anvendelige og virk-somme, nemlig- omtrent innen intervallet o,2 - l,o vektsprosent. o.5%, but also other concentrations are applicable and effective, namely roughly within the interval o.2 - 1.0 percent by weight.
Vannlosningen som inneholder natriumklorid og melkesyre innstilles med fordel ved hjelp av natriumhydroksyd på den onskede pH-verdien, nemlig innen intervallet 3 - 6 og spesielt pH 4. The aqueous solution containing sodium chloride and lactic acid is advantageously adjusted with the help of sodium hydroxide to the desired pH value, namely within the range 3 - 6 and especially pH 4.
Den ovenfor beskrevne losningen kan ifolge oppfinnelsen anvendes på to måter, nemlig delvis for vasking eller behandling av anal/genitalregionen samt tilg<o>rensende hudoverflater hos spebarn, men også hos voksne, f.eks. kronisk lammede eller på annen måte bevegelseshemmede personer, for å forhindre opptreden av hudirritasjoner samt rodning og sårdannelse eller for å lege allerede oppstått sådan, samt delvis for å fukte en konvensjonell bleie av mykt fuktighetsabsorberende materiale, f.eks. cellstoff av forskjellige typer. Bleien kan eksempelvis bestå av hvilket som helst porost smidig og våtsterkt materiale, gjerne våtsterkt papir eller poros plast eller fibermateriale. Den mengden av losningen som anvendes for å fukte bleiematerialet er hoyden den som forårsaker utrenning eller dryppning av losningen fra den fuktede bleien. Den minste anvendte mengde av losningen er den som stadig gir fuktning av huden ved bleiens kontakt med denne. Den ovenfor beskrevne vannlosningen utover eksempelvis sin virkning i situ, d.v.s. på huden. According to the invention, the solution described above can be used in two ways, namely partially for washing or treating the anal/genital region as well as adjacent skin surfaces in infants, but also in adults, e.g. chronically paralyzed or otherwise immobilized people, to prevent the occurrence of skin irritations as well as redness and ulceration or to heal already occurring ones, as well as partly to moisten a conventional nappy made of soft moisture-absorbing material, e.g. cellular matter of different types. The nappy can, for example, consist of any porous, flexible and wet-resistant material, preferably wet-resistant paper or porous plastic or fiber material. The amount of the solution used to wet the diaper material is the amount that causes the solution to drain or drip from the wetted diaper. The smallest amount of the solution used is the one that continuously moistens the skin when the nappy comes into contact with it. The above-described water release beyond, for example, its effect in situ, i.e. on the skin.
Formen på selve våtbleien er i og for seg selvfolgelig ikke kritisk, men det kan være gunstig å utforme denne rektangulært, hvorved den kan anbringes ovenpå konvensjonelle bleier av cellulosemateriale, d.v.s. mellom den konvensjonelle bleien og huden. Den kan også holdes på plass av et par nattbukser. Alternativt kan bleien ifolge oppfinnelsen med fordel utformes på en slik måte at den kan anbringes uten å bæres oppe av en konvensjonell bleie eller et konvensjonelt bleietorkle, hvorved den med fordel gis samme form som et såkalt bleietorkle og festes eller.knyttes på spebarnet på vanlig forekommende måte. The shape of the wet nappy itself is therefore not critical in and of itself, but it can be beneficial to design it rectangular, whereby it can be placed on top of conventional nappies made of cellulose material, i.e. between the conventional diaper and the skin. It can also be held in place by a pair of night pants. Alternatively, the nappy according to the invention can advantageously be designed in such a way that it can be placed without being carried up by a conventional nappy or a conventional nappy cloth, whereby it is advantageously given the same shape as a so-called nappy cloth and attached or tied to the infant in the usual way manner.
Et aspekt av oppfinnelsen vedrorer således en våtbleie for spebarnsstell, som utmerker seg ved at den består av en på egnet måte tilskåret poros, helst våtsterk duk av papir eller lignende materiale.av poros plast eller fibermateriale som impregneres eller fuktes med den ovenfor angitte vannlosningen, og denne inneholder som de vesentligste komponenter natriumklorid, melkesyre og natriumlaktat og har en pH innen området 3-6, helst omtrent 4. One aspect of the invention thus relates to a wet nappy for infant care, which is distinguished by the fact that it consists of a suitably tailored porous, preferably wet-resistant cloth made of paper or similar material. of porous plastic or fiber material which is impregnated or moistened with the water solution specified above, and this contains as the most important components sodium chloride, lactic acid and sodium lactate and has a pH within the range 3-6, preferably about 4.
Den ovenfor beskrevne, fuktede våtbleien kan forpakkes i fuktig, tilstand i et vanntett omslag på vanlig forekommende måte. Alternativt kan den fuktede våtbleien torkes og forpakkes i torr tilstand på passende måte hvorved man for anvendelsen fukter bleien med en egnet avpasset mengde vann som opploser komponentene i den opprinnelige tilsatte vannlosningen. I dette tilfellet må man selvfolgelig påse at The above-described moistened wet nappy can be prepackaged in a moist state in a waterproof cover in the usual way. Alternatively, the moistened wet nappy can be dried and prepackaged in a dry state in a suitable manner, whereby for use the nappy is moistened with a suitably adjusted amount of water which dissolves the components in the original added water solution. In this case, one must obviously ensure that
man ikke anvender en alt for stor vannmengde, hvilket ville medfore at de aktive komponentene i losningen ble vasket bort. one does not use an excessively large amount of water, which would mean that the active components in the solution were washed away.
Våtbleien ifolge oppfinnelsen kan anvendes på flere forskjellige måter for å oppnå den tilsiktede bakteriekontrol-lerende virkningen. Således kan bleien i fuktet tilstand anvendes for avtorkning og rengjbring av anal/genitalregionen samt tilgrensende hudflater hvorved huden fuktes av den i bleien foreliggende vannlosningen som utover sin velgjorende effekt. Som ovenfor nevnt kan våtbleien ifolge oppfinnelsen også anvendes som tilsetning til en bleie av vanlig forekommende type og til slutt kan våtbleien ifolge oppfinnelsen anbringes alene eller under en nattbukse, eksempelvis når barnet er nakent og får da gjerne sitte på til bleien torker og barnet skal kles på. Den okningen i saltkonsentrasjonen som langsomt skjer ved at bleien torker i kontakt med huden fremkaller ikke svette, men en kraftig oket antimikrobiell og hudbeskyttende effekt. The wet nappy according to the invention can be used in several different ways to achieve the intended bacteria-controlling effect. Thus, the nappy in a wet state can be used for drying and cleaning the anal/genital region as well as adjacent skin surfaces, whereby the skin is moistened by the water release present in the nappy, which goes beyond its beneficial effect. As mentioned above, the wet nappy according to the invention can also be used as an addition to a nappy of the usual type and finally the wet nappy according to the invention can be placed alone or under a nightie, for example when the child is naked and can then sit on it until the nappy dries and the child needs to be dressed on. The increase in salt concentration that slowly occurs as the nappy dries in contact with the skin does not induce sweat, but a strongly increased antimicrobial and skin protective effect.
Våtbleien kan derfor normalt anvendes for ettervasking ved bleiebytte da huden samtidig fuktes momentant ved hjelp av våtbleien, men når tendens til rod hud oppstår, får våtbleien alene eller under nattbukser sitte på i eksempelvis 15 minutter mellom bytte av konvensjonell bleie og plast-bukser, hvor en bedre effekt oppnås. The wet nappy can therefore normally be used for post-washing when changing nappies as the skin is simultaneously moistened momentarily with the help of the wet nappy, but when a tendency to red skin occurs, the wet nappy alone or under night trousers can be left on for example 15 minutes between changing conventional nappies and plastic trousers, where a better effect is achieved.
Et annet aspekt ved oppfinnelsen vedrorer en vannlosningAnother aspect of the invention relates to a water release
av den ovenfor beskrevne sammensetning, som som sådan er egnet til anvendelse for vasking av huden for å motvirke den skadelige virkningen av alkalisering gjennom innvirkning av hudsekret, urin eller avforing. For i det minste i en viss grad å forhindre utbredelse eller drypping kan det eventuelt være gunstig å forskynde losningen med et konvensjonelt viskositetsokende middel. Slike midler er ålment kjente og kan eksempelvis være ulike typer av cellulose-derivater, f.eks. karboksymetylcellulose, alginater, gummi arabicum, agar-agar e.l. Storre mengder viskositetsokende midler kan også anvendes, hvorved losningen gelatiseres. Også gelformen av losningen bevirker imidlertid den velgjorende effekten, men altfor store mengder viskositetsokende midler er ikke onskelige, da dette kan forårsake en klebende virkning etter at hoveddelen av vannet er fordampet etter påforing på huden. of the composition described above, which as such is suitable for use in washing the skin to counteract the harmful effect of alkalization through the action of skin secretions, urine or faeces. In order to at least to a certain extent prevent spreading or dripping, it may be beneficial to speed up the release with a conventional viscosity-increasing agent. Such agents are widely known and can, for example, be various types of cellulose derivatives, e.g. carboxymethyl cellulose, alginates, gum arabic, agar-agar etc. Larger amounts of viscosity-increasing agents can also be used, whereby the solution gelates. However, the gel form of the solution also causes the beneficial effect, but excessively large amounts of viscosity-increasing agents are not desirable, as this can cause a sticky effect after the main part of the water has evaporated after application to the skin.
Losningen ifolge oppfinnelsen inneholder hovedsaklig vann, nemlig i en mengde over ca. 97%. Det kan derfor være kommersielt gunstig å oppbevare losningen i form av et konsentrat som for anvendelsen kan fortynnes til onsket konsentrasjon. Konsentratets torrstoffinnhold er ikke særlig kritisk, og oppfinnelsen er ikke begrenset til noe spesielt konsentrasjonsintervall. Selv meget hoye torrstoffinnhold eller til og med et praktisk talt vannfritt pulver som inneholder de aktive bestanddelene faller således innen oppfinnelsens ramme. Av praktiske grunner er det fordelaktig at den konsent-rerte losningen inneholder minst 2,5% melkesyre, lo% natriumklorid samt natriumhydroksyd i en mengde som gir en pH på The solution according to the invention mainly contains water, namely in an amount over approx. 97%. It can therefore be commercially advantageous to store the solution in the form of a concentrate which can be diluted to the desired concentration for use. The dry matter content of the concentrate is not particularly critical, and the invention is not limited to any particular concentration range. Even very high dry matter contents or even a practically water-free powder containing the active ingredients thus fall within the scope of the invention. For practical reasons, it is advantageous that the concentrated solution contains at least 2.5% lactic acid, 10% sodium chloride and sodium hydroxide in an amount which gives a pH of
3-6, spesielt omtrent 3,8.3-6, especially about 3.8.
Også konsentratet kan inneholde et fortykningsmiddel av ovenfor angitte type. The concentrate can also contain a thickening agent of the above type.
Oppbevaring av losningen ifolge oppfinnelsen i form av et konsentrat medforer også den fordelen at dette er praktisk talt ubegrenset holdbart og ingen tilvekst av mikroorganismer kan skje deri. Storing the solution according to the invention in the form of a concentrate also has the advantage that it has a practically unlimited shelf life and no growth of microorganisms can occur therein.
Det er uten videre åpenbart at de ovenfor beskrevne losningene eller konsentratene kan tilsettes andre midler for å oppnå spesielle effekter. Slike tilsatser er åpenbare for fagmannen og anses derfor for å falle innenfor oppfinnelsens ramme. It is obvious without further ado that the solutions or concentrates described above can be added to other agents to achieve special effects. Such additives are obvious to the person skilled in the art and are therefore considered to fall within the scope of the invention.
Oppfinnelsen belyses ved folgende utforingseksempel.The invention is illustrated by the following embodiment example.
Eksempel 1Example 1
Eksempel 2 Eksempel 3 Example 2 Example 3
For anvendelsen fortynnes dette konsentratet med 4 deler vann. For use, this concentrate is diluted with 4 parts water.
Samtlige losninger ifolge eksemplene ovenfor var utmerket velegnede for rengjoring av anal/genitalregionen hos spebarn samt for fuktning av bleier av konvensjonell type. All the solutions according to the above examples were excellently suitable for cleaning the anal/genital region in infants as well as for wetting nappies of the conventional type.
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7500219A SE7500219L (en) | 1975-01-09 | 1975-01-09 | VATBLOJA |
SE7514402A SE7514402L (en) | 1975-12-18 | 1975-12-18 | SOLUTION FOR SKIN TREATMENT |
Publications (1)
Publication Number | Publication Date |
---|---|
NO760052L true NO760052L (en) | 1976-07-12 |
Family
ID=26656574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO76760052A NO760052L (en) | 1975-01-09 | 1976-01-08 |
Country Status (7)
Country | Link |
---|---|
DE (1) | DE2600498A1 (en) |
DK (1) | DK2776A (en) |
FI (1) | FI760016A (en) |
FR (1) | FR2297038A1 (en) |
GB (1) | GB1498160A (en) |
NL (1) | NL7600111A (en) |
NO (1) | NO760052L (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4432429A1 (en) * | 1994-09-12 | 1996-03-14 | Heinz Prahm | Pharmaceutical concentrates contg. lactic acid |
WO1999025288A1 (en) * | 1997-11-14 | 1999-05-27 | The Procter & Gamble Company | Disposable absorbent article with a skin care composition on an apertured top sheet |
CN101588825A (en) * | 2006-11-17 | 2009-11-25 | Sca卫生用品公司 | Absorbent article |
BRPI0622142A2 (en) * | 2006-11-17 | 2014-05-06 | Sca Hygiene Prod Ab | ABSORBENT ARTICLE |
AU2013347233B2 (en) | 2012-11-14 | 2018-06-14 | Zyfoma Gmbh | Treatment element for use together with a dental implant part, treatment system and method for cleaning a dental implant part |
DE102013201883A1 (en) * | 2013-02-05 | 2014-08-07 | Urs Brodbeck | Treatment fluid for cleaning an implant part |
JP2023038161A (en) * | 2021-09-06 | 2023-03-16 | 花王株式会社 | Skin external preparation |
-
1975
- 1975-12-31 GB GB53249/75A patent/GB1498160A/en not_active Expired
-
1976
- 1976-01-06 FI FI760016A patent/FI760016A/fi not_active Application Discontinuation
- 1976-01-06 DK DK2776*#A patent/DK2776A/en not_active Application Discontinuation
- 1976-01-07 FR FR7600242A patent/FR2297038A1/en active Granted
- 1976-01-07 NL NL7600111A patent/NL7600111A/en not_active Application Discontinuation
- 1976-01-08 NO NO76760052A patent/NO760052L/no unknown
- 1976-01-08 DE DE19762600498 patent/DE2600498A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2297038B1 (en) | 1979-07-06 |
NL7600111A (en) | 1976-07-13 |
FI760016A (en) | 1976-07-10 |
GB1498160A (en) | 1978-01-18 |
DK2776A (en) | 1976-07-10 |
DE2600498A1 (en) | 1976-07-15 |
FR2297038A1 (en) | 1976-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3092552A (en) | Oligodynamic silver compositions and uses | |
TWI693929B (en) | Antibacterial wound dressing | |
Lim et al. | Normal saline wound dressing—is it really normal? | |
SE432194B (en) | MOISTURIZING AND BACTERIODIC ABSORPTION BODY FOR URINE AND FAECES, WHICH INCLUDE A WATER-SOLUBLE COPPER SALT | |
ES2897373T3 (en) | Wound dressing comprising an antimicrobial composition | |
PT91065B (en) | Process for the preparation of a natural preservative composition for humidifiers | |
CN101797086B (en) | Antibacterial deodorizing insoles | |
NO760052L (en) | ||
US4769021A (en) | Absorptive pads and method of making | |
BRPI0622143A2 (en) | ABSORBENT ARTICLE | |
US4849455A (en) | Glycerol containing virucidal compositions | |
JP6290184B2 (en) | Wound dressing | |
US6995297B1 (en) | Herb medicine composition to be contained in sanitary materials for infants | |
CN105381454B (en) | A kind of nasal cavity wetting agent containing trehalose | |
CN105412913B (en) | A kind of nasal cavity wetting agent | |
US4608044A (en) | Compress for treatment of wounds | |
DE69023965D1 (en) | Super absorbent wound dressing. | |
SHARE et al. | Effect of potassium on the movement of water across the isolated amphibian skin | |
EP0224494B1 (en) | Absorptive pads and method of making | |
CN106983903A (en) | Moist dressing of function and preparation method thereof is indicated with soda acid | |
US20040001791A1 (en) | Composition, method of use, and devices for the treatment of onychomycosis | |
JPS5758624A (en) | Sanitary treating agent for clothing and footwear | |
JPH057361B2 (en) | ||
CN105055439B (en) | A kind of microecology in vaginas maintenance, health care and prevention preparation and preparation method and application | |
GB899965A (en) | Improvements in surgical dressings |